| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,681 |
13,453 |
$436K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,870 |
2,481 |
$116K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,854 |
1,701 |
$108K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,557 |
4,227 |
$69K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,110 |
986 |
$53K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
499 |
475 |
$30K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,298 |
2,091 |
$28K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
308 |
286 |
$25K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
318 |
265 |
$17K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
349 |
318 |
$8K |
| 99215 |
Prolong outpt/office vis |
73 |
65 |
$4K |
| 85018 |
|
1,767 |
1,637 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
116 |
102 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
263 |
122 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
29 |
27 |
$2K |
| 90474 |
|
241 |
213 |
$2K |
| 90686 |
|
760 |
722 |
$2K |
| 90670 |
|
543 |
489 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
13 |
12 |
$1K |
| 0064A |
|
66 |
49 |
$789.00 |
| 90671 |
|
138 |
125 |
$745.96 |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
18 |
12 |
$532.81 |
| 11721 |
|
25 |
25 |
$381.01 |
| 83655 |
|
32 |
29 |
$250.21 |
| 90698 |
|
217 |
192 |
$212.16 |
| 90680 |
|
241 |
213 |
$206.80 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13 |
13 |
$109.12 |
| 90697 |
|
54 |
49 |
$99.58 |
| 90744 |
|
59 |
52 |
$66.61 |
| 90656 |
|
29 |
29 |
$18.40 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
92 |
81 |
$3.83 |
| 0071A |
|
19 |
14 |
$0.00 |
| 90633 |
|
12 |
12 |
$0.00 |